Catheter salvage therapy was preferred over CVL removal for CLABSI management in pediatric patients with SBS on long-term TPN.

The WRAPSODY CIE received premarket approval (PMA) from the US Food and Drug Administration (FDA) in December 2024. Merit began commercialization of the device in the United States in January 2025.

Marco Scorcu, vice-president of the Federation of Sports Doctors and Cagliari doctor, shared in 'La Gazzetta dello Sport' his particular theory on the use of wristbands by Barcelon ...

BVT is a useful autologous procedure for hemodialysis and the preferred access alternative in patients without an adequate cephalic vein. Although patencies remain poor relative to other ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & ...

In Spain, a case erupts just days before the second leg of the semifinal between Inter and Barcelona, which will determine ...

Let’s dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q1 surgical ...

New data finds women 8% more likely to experience major complications after transcatheter aortic valve implantation (TAVI) ...

A new hybrid operating room combines a surgical suite with advanced imaging technology to treat patients with complex ...

To use the da Vinci 5 robotic system, the surgeon sits at a console about 10 feet away from the patient and performs the ...

Introducing the "Los Mogotes" target cluster Toronto, Ontario--(Newsfile Corp.) - Mogotes Metals Inc. (TSXV: MOG) (FSE: OY4) ...

Tactile Systems Technology, Inc.’s TCMD share price has dipped by 33.21%, which has investors questioning if this is right ...